Arroyo Vista Family Health Foundation
Arroyo Vista Family Health Foundation was paid $19.87M by Medicaid between Jan 2018 and Dec 2024, across 185 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 76% of everything it billed.
33Billing provider infoARROYO VISTA FAMILY HEALTH FOUNDATION
LOS ANGELES, CA 90042
LOS ANGELES, CA 90042
33aNPI1447353701assigned 09/05/2006
33bProvider typeCase Manager/Care Coordinator
28Total paid$19.87M
24GClaims804,923
24DCodes billed185
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Case Manager/Care Coordinator providers in California
Rank by total paid#100 of 435
Median peer was paid$2.89M
This provider vs. median6.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 81,665 | $2.56M | |
| 2019 | 68,204 | $2.43M | |
| 2020 | 72,058 | $2.29M | |
| 2021 | 103,045 | $3.38M | |
| 2022 | 145,055 | $2.67M | |
| 2023 | 103,225 | $3.34M | |
| 2024incomplete | 231,671 | $3.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 76% | 123,593 | 103,502 | $15.06M |
| 00003 | Internal/system code - not a standard HCPCS code | 11% | 11,800 | 9,592 | $2.18M |
| G9012 | Other specified case management service not elsewhere classified | 1.5% | 4,273 | 2,090 | $298K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.3% | 6,485 | 6,482 | $268K |
| 0012A | <1% | 3,237 | 2,318 | $155K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 154,096 | 109,712 | $139K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 6,794 | 5,277 | $137K |
| G9008 | Coordinated care fee, physician coordinated care oversight services | <1% | 3,848 | 2,420 | $133K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 6,500 | 5,276 | $132K |
| 0011A | <1% | 2,701 | 2,179 | $114K | |
| 0064A | <1% | 2,168 | 1,595 | $105K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 5,449 | 4,400 | $100K |
173 more codes
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 2,738 | $71K |
| 92551 | <1% | 15,773 | $58K | |
| 0001A | <1% | 1,082 | $53K | |
| 0002A | <1% | 1,064 | $53K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 29,771 | $53K |
| V2020 | Frames, purchases | <1% | 7,103 | $52K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,778 | $50K |
| 90686 | <1% | 10,692 | $48K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 21,305 | $47K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 4,808 | $46K |
| 0004A | <1% | 852 | $39K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,285 | $36K |
| G0467 | Community health center visit, returning patient | <1% | 1,694 | $32K |
| 92015 | Determination of refractive state | <1% | 10,345 | $28K |
| 92002 | <1% | 1,368 | $25K | |
| 92341 | <1% | 1,886 | $25K | |
| 0071A | <1% | 449 | $23K | |
| 0072A | <1% | 421 | $21K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 503 | $21K |
| 59425 | <1% | 930 | $20K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,121 | $16K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 18,065 | $14K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 831 | $13K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 6,429 | $13K |
| 0134A | <1% | 211 | $12K | |
| 91322 | <1% | 99 | $12K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,162 | $11K |
| 90480 | <1% | 293 | $11K | |
| 0124A | <1% | 165 | $10K | |
| 91320 | <1% | 103 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,248 | $9K |
| 85018 | <1% | 14,880 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 691 | $9K |
| 90715 | <1% | 774 | $7K | |
| 0054A | <1% | 125 | $7K | |
| 90670 | <1% | 1,312 | $7K | |
| 90651 | <1% | 1,342 | $6K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 508 | $5K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 294 | $5K |
| 92552 | <1% | 483 | $5K | |
| 90734 | <1% | 755 | $4K | |
| 90648 | <1% | 878 | $4K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 64 | $3K |
| 99173 | <1% | 1,437 | $3K | |
| 59430 | <1% | 487 | $3K | |
| 90633 | <1% | 408 | $3K | |
| 81002 | <1% | 18,534 | $3K | |
| 76801 | <1% | 269 | $2K | |
| 90837 | Psychotherapy session, about an hour | <1% | 95 | $2K |
| 83026 | <1% | 808 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 226 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 332 | $2K |
| 90620 | <1% | 350 | $2K | |
| 90619 | <1% | 375 | $2K | |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 223 | $1K |
| 76770 | <1% | 77 | $1K | |
| 81025 | <1% | 948 | $1K | |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 761 | $988.00 |
| D0210 | Intraoral - complete series of radiographic images | <1% | 690 | $983.00 |
| 90723 | <1% | 334 | $945.00 | |
| 90710 | <1% | 103 | $927.00 | |
| 93000 | <1% | 99 | $925.60 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,522 | $881.28 |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 80 | $848.88 |
| D4341 | <1% | 502 | $800.00 | |
| 92081 | <1% | 9,428 | $782.88 | |
| 0052A | <1% | 17 | $680.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 600 | $557.18 |
| 73030 | <1% | 42 | $484.64 | |
| 90697 | <1% | 232 | $459.00 | |
| 90671 | <1% | 199 | $441.00 | |
| D0120 | Dental checkup, returning patient | <1% | 120 | $288.00 |
| 90696 | <1% | 30 | $270.00 | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 840 | $270.00 |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 87 | $237.80 |
| 90649 | <1% | 61 | $198.00 | |
| 73560 | <1% | 32 | $195.73 | |
| 73630 | <1% | 14 | $135.12 | |
| 90716 | <1% | 30 | $135.00 | |
| 90700 | <1% | 15 | $135.00 | |
| 82948 | <1% | 10,878 | $132.56 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 223 | $119.00 |
| 90707 | <1% | 26 | $117.00 | |
| D1206 | Topical application of fluoride varnish | <1% | 110 | $115.00 |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 21 | $102.90 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 14 | $90.78 |
| 86580 | <1% | 158 | $89.14 | |
| D1110 | Prophylaxis - adult | <1% | 60 | $51.50 |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 20 | $45.10 |
| 1126F | <1% | 17,253 | $40.00 | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 158 | $17.70 |
| 80061 | Lipid panel | <1% | 699 | $15.12 |
| 99070 | <1% | 39 | $7.50 | |
| 81001 | <1% | 534 | $1.12 | |
| 80053 | Comprehensive metabolic panel | 0% | 705 | $0.00 |
| 1123F | 0% | 2,042 | $0.00 | |
| 3351F | 0% | 2,423 | $0.00 | |
| 1036F | 0% | 25,007 | $0.00 | |
| 3074F | 0% | 10,563 | $0.00 | |
| 3044F | 0% | 12,599 | $0.00 | |
| 3008F | 0% | 24,400 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 608 | $0.00 |
| 3079F | 0% | 5,440 | $0.00 | |
| 1170F | 0% | 11,566 | $0.00 | |
| 4010F | 0% | 9,891 | $0.00 | |
| 1220F | 0% | 3,621 | $0.00 | |
| 2023F | 0% | 145 | $0.00 | |
| 82962 | 0% | 84 | $0.00 | |
| 3014F | 0% | 1,763 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 933 | $0.00 |
| D0140 | Limited oral evaluation - problem focused | 0% | 46 | $0.00 |
| 3075F | 0% | 3,354 | $0.00 | |
| 3352F | 0% | 2,180 | $0.00 | |
| 1000F | 0% | 6,614 | $0.00 | |
| 3353F | 0% | 37 | $0.00 | |
| 3080F | 0% | 945 | $0.00 | |
| D0601 | 0% | 60 | $0.00 | |
| 3052F | 0% | 131 | $0.00 | |
| 1125F | 0% | 2,630 | $0.00 | |
| 4037F | 0% | 3,492 | $0.00 | |
| 1101F | 0% | 1,059 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 1,688 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 195 | $0.00 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 64 | $0.00 |
| Z1034 | 0% | 262 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 25 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 504 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 408 | $0.00 |
| 90474 | 0% | 27 | $0.00 | |
| 88142 | 0% | 28 | $0.00 | |
| 3061F | 0% | 37 | $0.00 | |
| 1034F | 0% | 160 | $0.00 | |
| 3354F | 0% | 251 | $0.00 | |
| 99172 | 0% | 25 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 15 | $0.00 |
| 86592 | 0% | 115 | $0.00 | |
| 76536 | 0% | 13 | $0.00 | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | 0% | 137 | $0.00 |
| 82607 | 0% | 12 | $0.00 | |
| 90677 | 0% | 23 | $0.00 | |
| 0509F | 0% | 19 | $0.00 | |
| 99381 | 0% | 14 | $0.00 | |
| 1160F | 0% | 16,825 | $0.00 | |
| 99442 | 0% | 25,901 | $0.00 | |
| 4025F | 0% | 6,036 | $0.00 | |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | 0% | 1,465 | $0.00 |
| 1124F | 0% | 3,150 | $0.00 | |
| 3077F | 0% | 2,401 | $0.00 | |
| 3051F | 0% | 769 | $0.00 | |
| 1090F | 0% | 306 | $0.00 | |
| 3725F | 0% | 3,551 | $0.00 | |
| 1158F | 0% | 5,379 | $0.00 | |
| 1159F | 0% | 16,860 | $0.00 | |
| 3078F | 0% | 10,654 | $0.00 | |
| 3015F | 0% | 1,354 | $0.00 | |
| 3062F | 0% | 299 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 459 | $0.00 |
| 3046F | 0% | 1,022 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 225 | $0.00 |
| 72100 | 0% | 65 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 12 | $0.00 |
| 2028F | 0% | 381 | $0.00 | |
| 4040F | 0% | 615 | $0.00 | |
| 3288F | 0% | 12 | $0.00 | |
| 99201 | 0% | 141 | $0.00 | |
| 84439 | 0% | 73 | $0.00 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 25 | $0.00 |
| 91313 | 0% | 14 | $0.00 | |
| 90681 | 0% | 57 | $0.00 | |
| 87806 | 0% | 106 | $0.00 | |
| 84550 | 0% | 14 | $0.00 | |
| 4274F | 0% | 111 | $0.00 | |
| 91300 | 0% | 57 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialESTRADAS, LORRAINE (CHIEF EXECUTIVE OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Arroyo Vista Family Health Foundation | Los Angeles, CA | $10.69M |
| Arroyo Vista Family Health Foundation | Los Angeles, CA | $3.93M |
| Arroyo Vista Family Health Foundation | Los Angeles, CA | $3.13M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.